Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU) - Trial NCT05658913
Access comprehensive clinical trial information for NCT05658913 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Pennsylvania and is currently Recruiting. The study focuses on Alzheimer's Disease. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Pennsylvania
Timeline & Enrollment
N/A
Mar 15, 2023
Dec 01, 2029
Primary Outcome
Clusters based on spatial pattern and extent of T-N Mismatch
Summary
To collect Tau PET/CT imaging in older adults diagnosed with Mild Cognitive Impairment (MCI)
 or Alzheimer's Disease (AD) in the Mismatch Prospective Cohort Study (MPC-Tau) study to
 determine relationship to clinical, cognitive, and other biomarker data. Findings from this
 study will likely provide insight into the phenotypic variability of Alzheimer's Disease and
 other related pathologies.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05658913
Non-Device Trial